HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sarah Adriana Scuderi Selected Research

4-phenylbutanoyl-prolylcyanopyrrolidine

12/2021Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma.
7/2021KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sarah Adriana Scuderi Research Topics

Disease

5Neoplasms (Cancer)
02/2022 - 07/2021
3Mouth Neoplasms (Oral Cancer)
12/2021 - 07/2021
2Inflammation (Inflammations)
03/2022 - 10/2020
2Squamous Cell Carcinoma of Head and Neck
12/2021 - 10/2021
2Traumatic Brain Injuries (Traumatic Brain Injury)
08/2021 - 01/2021
2Neuroinflammatory Diseases
01/2021 - 10/2020
1Migraine Disorders (Migraine)
04/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
03/2022
1Acute Lung Injury
08/2021
1Ischemia
08/2021
1Glioblastoma (Glioblastoma Multiforme)
07/2021
1Carcinoma (Carcinomatosis)
07/2021
1Wounds and Injuries (Trauma)
01/2021
1Gliosis
01/2021
1Venous Insufficiency
12/2020
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
11/2020
1Edema (Dropsy)
11/2020
1Diarrhea
11/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2020

Drug/Important Bio-Agent (IBA)

3Prolyl OligopeptidasesIBA
08/2021 - 12/2020
24-phenylbutanoyl-prolylcyanopyrrolidineIBA
12/2021 - 07/2021
2InflammasomesIBA
10/2021 - 11/2020
23- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
10/2021 - 11/2020
1Volatile Fatty AcidsIBA
04/2022
1Butyric Acid (Butanoic Acid)IBA
04/2022
1sodium propionateIBA
04/2022
1MelatoninIBA
03/2022
1CytokinesIBA
03/2022
1Biomarkers (Surrogate Marker)IBA
02/2022
1Biological ProductsIBA
02/2022
1MicroRNAs (MicroRNA)IBA
02/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021
1oligopeptidaseIBA
12/2021
1LuteolinIBA
08/2021
1FlavonoidsIBA
08/2021
1palmidrolIBA
08/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
07/2021
1veliparibIBA
07/2021
1Cisplatin (Platino)FDA LinkGeneric
07/2021
1MTOR InhibitorsIBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1TOR Serine-Threonine KinasesIBA
01/2021
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2020
1ElementsIBA
10/2020
1EnzymesIBA
10/2020
1Interferon-gamma (Interferon, gamma)IBA
10/2020
1LipopolysaccharidesIBA
10/2020
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2020

Therapy/Procedure

2Therapeutics
04/2022 - 07/2021